3.1.4 Compound bronchodilator preparations

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

11 library items in 3.1.4 Compound bronchodilator preparations

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

3: Respiratory system (remove) , 3.1 Bronchodilators (remove) , 3.1.4 Compound bronchodilator preparations (remove)

Sort by: Display summary:

Results 1 - 10 of 11

Result page:
Previous
|
1
2
|
Next

1.

CFC-free Combivent Respimat (ipratropium bromide and salbutamol inhaler) approved in US for the treatment of COPD

Source: BioSpace ,
Date published: 12/10/2011

Category:

3.1.4 Compound bronchodilator preparations | Chronic Obstructive Airways Disease

NeLM Area:

News

Link
2.

Duovent UDVs (1.25mg Fenoterol hydrobromide & 0.5mg Ipratropium bromide)-Product discontinuation

Source: Boehringer Ingelheim,
Date published: 01/12/2010

Category:

3.1.4 Compound bronchodilator preparations | Asthma | Product Discontinuation

NeLM Area:

Other Library Updates > SPC Changes
3.

FDA finalises new warnings for inhaled long-acting beta agonists

Source: Reuters Health,
Date published: 03/06/2010

Category:

3.1.1 Adrenoceptor agonists | 3.1.4 Compound bronchodilator preparations | Food &Drug Administration (FDA)

NeLM Area:

News

Link Full Access Requires Registration with Reuters Health

NeLM report of FDA warnings Feb 2010

FDA MedWatch release (added 04.06.10)
4.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease

Source: Cochrane Library,
Date published: 17/05/2010

Category:

3.1.2 Antimuscarinic bronchodilators | 3.1.4 Compound bronchodilator preparations | Chronic Obstructive Airways Disease

NeLM Area:

Evidence > Drug Class Focused Reviews

Review
5.

Duovent UDVs (fenoterol / ipratopium) - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 21/06/2009

Category:

3.1.4 Compound bronchodilator preparations | Asthma

NeLM Area:

Other Library Updates > SPC Changes

SPC
6.

Combivent metered aerosol and UDVs (salbutamol, ipratropium) - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 13/01/2009

Category:

3.1.4 Compound bronchodilator preparations | Asthma | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

Link to SPC

Link to SPC
7.

FDA safety review on long-acting beta agonist drugs and related meta-analysis

Source: Reuters Health, Am J Respir Cnt Care Med,
Date published: 08/12/2008

Category:

3.1 Bronchodilators | 3.1.4 Compound bronchodilator preparations | Adverse Drug Reactions | Asthma | Food &Drug Administration (FDA) | Paediatrics | Product Licence Changes

NeLM Area:

News

Link to FDA story

Study abstract
8.

Combivent inhaler (ipratropium and salbutamol) - discontinued, 19/07/2008

Source: Chemist and Druggist,
Date published: 02/09/2008

Category:

3.1.4 Compound bronchodilator preparations | Asthma | Chronic Obstructive Airways Disease

NeLM Area:

Other Library Updates > SPC Changes
9.

NPC iblog: Reminder of discontinuation of ipratropium/salbutamol inhaler

Source: NPC,
Date published: 14/07/2008

Category:

3.1.4 Compound bronchodilator preparations | Asthma | Drug shortages

NeLM Area:

News

NPC iblog
10.

Chronic obstructive pulmonary disease: NICE Guideline

Source: NICE,
Date published: 25/02/2004

Category:

3.1.1 Adrenoceptor agonists | 3.1.2 Antimuscarinic bronchodilators | 3.1.3 Theophylline | 3.1.4 Compound bronchodilator preparations | 3.2 Corticosteroids | 3.6 Oxygen | 3.7 Mucolytics | 5.1 Antibacterial drugs | 5.3.4 Influenza | 14.4 Vaccines and antisera | Chronic Obstructive Airways Disease

NeLM Area:

Evidence > Guidelines

http://guidance.nice.org.uk/CG12

Results 1 - 10 of 11

Result page:
Previous
|
1
2
|
Next